Ubs Asset Management Americas Inc Tg Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 161,927 shares of TGTX stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,927
Previous 161,927
-0.0%
Holding current value
$3.04 Million
Previous $2.77 Million
10.96%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding TGTX
# of Institutions
269Shares Held
87.7MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$254 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$146 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$65.5 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$62.5 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.73B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...